scholarly journals To what extent are the terminal stages of sepsis, septic shock, SIRS, and multiple organ dysfunction syndrome actually driven by a prion/amyloid form of fibrin?

2016 ◽  
Author(s):  
Douglas B. Kell ◽  
Etheresia Pretorius

AbstractA well-established development of increasing disease severity leads from sepsis through septic shock, SIRS, multiple organ dysfunction syndrome and cellular and organismal death. We argue that a chief culprit is the LPS-induced anomalous coagulation of fibrinogen to produce a form of fibrin that is at once inflammatory, resistant to fibrinolysis, and underpins the disseminated intravascular coagulation commonly observed in sepsis. In particular, we argue that the form of fibrin produced is anomalous because much of its normal α-helical content is transformed to β-sheets, as occurs in established amyloidogenic and prion diseases. We hypothesise that these processes play a major role in the passage along the above pathways to organismal death, and that inhibiting them would be of great therapeutic value, a claim for which there is emerging evidence.

2017 ◽  
Vol 44 (03) ◽  
pp. 224-238 ◽  
Author(s):  
Douglas Kell ◽  
Etheresia Pretorius

AbstractA well-established development of increasing disease severity leads from sepsis through systemic inflammatory response syndrome, septic shock, multiple organ dysfunction syndrome, and cellular and organismal death. Less commonly discussed are the equally well-established coagulopathies that accompany this. We argue that a lipopolysaccharide-initiated (often disseminated intravascular) coagulation is accompanied by a proteolysis of fibrinogen such that formed fibrin is both inflammatory and resistant to fibrinolysis. In particular, we argue that the form of fibrin generated is amyloid in nature because much of its normal α-helical content is transformed to β-sheets, as occurs with other proteins in established amyloidogenic and prion diseases. We hypothesize that these processes of amyloidogenic clotting and the attendant coagulopathies play a role in the passage along the aforementioned pathways to organismal death, and that their inhibition would be of significant therapeutic value, a claim for which there is considerable emerging evidence.


PLoS ONE ◽  
2019 ◽  
Vol 14 (12) ◽  
pp. e0225423
Author(s):  
Allen Chung-Cheng Huang ◽  
Tim Yu-Ting Lee ◽  
Meng-Cheng Ko ◽  
Chih-Hsien Huang ◽  
Tsai-Yu Wang ◽  
...  

2008 ◽  
Vol 45 (1) ◽  
pp. 106-116 ◽  
Author(s):  
Jeng-Yuan Wu ◽  
Mei-Yung Tsou ◽  
Tai-Hao Chen ◽  
Shiu-Jen Chen ◽  
Cheng-Ming Tsao ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-6
Author(s):  
Mario Pezzi ◽  
Anna Maria Scozzafava ◽  
Anna Maria Giglio ◽  
Renata Vozzo ◽  
Patrizia Dina Casella ◽  
...  

Multiresistant bacteria infections cause widespread morbidity and mortality and lead to an increase in expenses for hospital stays and complications. We describe the case of a 27-year-old patient with puerperal sepsis after cesarean section due to Escherichia coli complicated by multiresistant Klebsiella ESBL-producing superinfection with septic shock and multiple organ dysfunction syndrome, successfully treated with ceftolozane/tazobactam.


Sign in / Sign up

Export Citation Format

Share Document